September 25, 2024
TOPLINE: Electronic health record (EHR)–derived family history identified 29,913 patients with familial risk for hereditary breast and ovarian cancer, but 82% had no evidence of genetic […]
September 25, 2024
TOPLINE: Treatment-resistant major depression (TRD) is associated with a 17% higher risk for all-cause mortality than non-TRD major depressive disorder (MDD), a new study shows. The […]
September 25, 2024
TOPLINE: Menopausal hormone therapy (MHT) is associated with a 16% lower risk for psychosis relapse in women with schizophrenia or schizoaffective disorder (SSD), especially in women […]
September 25, 2024
TOPLINE: Survival rates for patients with hepatocellular carcinoma (HCC) have improved, but overall survival remains low. Early detection and treatment significantly enhanced survival outcomes between January […]
September 25, 2024
TOPLINE: The prevalence of diabetes in the United States increased by 18.6% from 2012 to 2022, with notably higher rates among racial and ethnic minorities, men, […]
September 25, 2024
TOPLINE: In patients with rectal cancer, having persistent lymph node metastases after neoadjuvant chemoradiotherapy is associated with worse overall survival outcomes and higher rates of recurrence […]
September 24, 2024
TOPLINE: Patients with breast cancer carrying TP53 pathogenic variants face an 8.8% cumulative risk for developing sarcoma within 15 years of receiving radiotherapy. However, the 10-year […]
September 24, 2024
TOPLINE: Maternal short sleep duration during pregnancy is linked to an increased risk for neurodevelopmental delays in offspring, particularly in boys. The study suggests that higher […]
September 24, 2024
TOPLINE: The prevalence of obesity among US adults is 40.3%, and the prevalence of severe obesity is 9.4%, according to the latest data (2021-2023) from the […]